Ilse Smolders Selected Research

Ilse Smolders Research Topics

Disease

43	Seizures (Absence Seizure) 01/2023 - 08/2002
25	Epilepsy (Aura) 01/2023 - 08/2002
8	Status Epilepticus (Complex Partial Status Epilepticus) 01/2023 - 06/2010
8	Parkinson Disease (Parkinson's Disease) 03/2017 - 10/2008
7	Temporal Lobe Epilepsy 01/2023 - 05/2011
4	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2011
3	Disease Progression 01/2023 - 01/2015
3	Cognitive Dysfunction 01/2021 - 01/2008
3	Drug Resistant Epilepsy 01/2015 - 01/2007
3	Memory Disorders (Memory Loss) 04/2011 - 07/2009
2	Inflammation (Inflammations) 01/2018 - 02/2006
2	Nervous System Diseases (Neurological Disorders) 01/2015 - 03/2013
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 03/2021
1	Wounds and Injuries (Trauma) 03/2021
1	Body Weight (Weight, Body) 01/2021
1	Dementia (Dementias) 01/2021
1	Oculodentodigital Dysplasia 11/2020
1	Obesity 01/2020
1	AIDS-Related Complex (ARC) 01/2020
1	Neuroinflammatory Diseases 01/2019
1	Anhedonia 01/2018
1	Encephalitis (Encephalitis, Rasmussen) 01/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2017
1	Parkinsonian Disorders (Parkinsonism) 01/2017
1	Treatment-Resistant Depressive Disorder 01/2017

Drug/Important Bio-Agent (IBA)

24	Anticonvulsants (Antiepileptic Drugs)IBA 10/2022 - 03/2004
23	Pilocarpine (Ocusert)FDA LinkGeneric 01/2022 - 08/2002
15	Glutamic Acid (Glutamate)FDA Link 11/2020 - 08/2002
10	LigandsIBA 12/2021 - 03/2004
9	Dopamine (Intropin)FDA LinkGeneric 03/2017 - 12/2004
7	Serotonin (5 Hydroxytryptamine)IBA 05/2015 - 05/2004
6	Pentylenetetrazole (Metrazol)IBA 10/2022 - 07/2009
5	Kainic Acid (Kainate)IBA 01/2023 - 06/2010
5	GhrelinIBA 12/2021 - 04/2012
5	Proteins (Proteins, Gene)FDA Link 11/2020 - 08/2005
5	gamma-Aminobutyric Acid (GABA)IBA 04/2015 - 08/2002
4	Cystine (L-Cystine)IBA 01/2019 - 10/2008
4	Neurotransmitter Agents (Neurotransmitter)IBA 05/2015 - 01/2008
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 05/2011
3	Ghrelin ReceptorsIBA 12/2021 - 06/2015
3	AntiportersIBA 01/2019 - 10/2008
3	Peptides (Polypeptides)IBA 01/2018 - 01/2008
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 08/2015 - 08/2006
3	AngiotensinsIBA 05/2015 - 01/2008
3	Citalopram FDA LinkGeneric 05/2012 - 12/2004
3	des-Asp(1)-des-Arg(2)-Ile(5)- angiotensin IIIBA 03/2010 - 08/2006
2	Protein Isoforms (Isoforms)IBA 01/2022 - 02/2006
2	Glycogen Synthase Kinase 3IBA 01/2022 - 01/2019
2	macimorelinIBA 01/2021 - 05/2019
2	MelatoninIBA 01/2021 - 01/2021
2	Connexin 43 (Connexin43)IBA 11/2020 - 01/2018
2	CitrullineIBA 09/2020 - 05/2005
2	Serine (L-Serine)FDA Link 01/2018 - 09/2015
2	lactacystinIBA 01/2017 - 01/2015
2	NAD (NADH)IBA 01/2017 - 05/2015
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 05/2015 - 05/2011
2	Diazepam (Valium)FDA LinkGeneric 04/2015 - 06/2010
2	EnzymesIBA 04/2015 - 02/2006
2	Vesicular Glutamate Transport ProteinsIBA 03/2015 - 01/2011
2	Glutathione (Reduced Glutathione)IBA 06/2014 - 04/2011
2	NeuropeptidesIBA 07/2012 - 04/2012
2	Reboxetine (Vestra)IBA 05/2012 - 11/2011
2	ConvulsantsIBA 05/2012 - 08/2006
2	Antidepressive Agents (Antidepressants)IBA 05/2012 - 11/2011
2	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2008 - 03/2004
2	3,4-dihydroxyphenylglycolIBA 01/2008 - 03/2004
2	5-HT1A Serotonin ReceptorIBA 12/2005 - 05/2004
2	Amino Acids FDA Link 05/2005 - 03/2004
1	pyrazoleIBA 10/2022
1	TCS2002IBA 01/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2021
1	disodium salt olean-11,13(18)-diene-3,30-diol dihemiphthalateIBA 11/2020
1	Lysine (L-Lysine)FDA Link 09/2020
1	Phenylalanine (L-Phenylalanine)FDA Link 09/2020
1	3-methyladenineIBA 09/2020
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 09/2020
1	Histidine (L-Histidine)FDA Link 09/2020
1	Methionine (L-Methionine)FDA Link 09/2020
1	neuromedin U 8IBA 01/2020
1	YIL 781IBA 05/2019
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2019
1	6-bromoindirubin-3'-acetoximeIBA 01/2019
1	Plant ExtractsIBA 01/2019
1	indirubinIBA 01/2019
1	TAT-Gap19 peptideIBA 01/2018
1	CytokinesIBA 01/2018
1	LipopolysaccharidesIBA 01/2018
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2018
1	EndotoxinsIBA 01/2018
1	N- ((5- (3- (1- benzylpiperidin- 4- yl)propoxy)- 1- methyl- 1H- indol- 2- yl)methyl)- N- methylprop- 2- yn- 1- amineIBA 03/2017
1	Zonisamide (Zonegran)FDA LinkGeneric 01/2017
1	Therapeutic UsesIBA 01/2017
1	Neuroprotective AgentsIBA 01/2016
1	Oxidopamine (6 Hydroxydopamine)IBA 09/2015

Therapy/Procedure

7	Therapeutics 01/2020 - 08/2002
2	Vagus Nerve Stimulation 01/2015 - 05/2011
1	Transcranial Direct Current Stimulation 03/2021
1	Electrodes (Electrode) 01/2019
1	Injections 01/2018
1	Transcranial Magnetic Stimulation 01/2017